ArticleThe American journal of case reports2026
Postoperative Corneal Dellen Following PreserFlo MicroShunt: A Case Report.
Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND The PreserFlo MicroShunt is a subconjunctival drainage device increasingly used to manage open-angle glaucoma. While its safety profile is considered favorable compared with that of trabeculectomy, rare postoperative complications, including corneal surface pathology, can still be encountered. To our knowledge, corneal dellen has not been previously reported following PreserFlo implantation. CASE REPORT A 15-year-old boy with pathological myopia and Stickler syndrome underwent PreserFlo MicroShunt implantation for refractory secondary open-angle glaucoma. Two weeks postoperatively, he developed a temporal area of corneal stromal thinning consistent with dellen, located adjacent to an elevated bleb in the horizontal plane. Conservative therapy, including a switch from prednisolone acetate to loteprednol etabonate, intensive preservative-free lubrication, autologous serum drops, and bandage contact lens placement, was initiated. Full corneal re-epithelialization and recovery were achieved within 1 week, without compromising bleb function or intraocular pressure control. CONCLUSIONS Corneal dellen is a potential, although previously undocumented, complication of PreserFlo MicroShunt surgery, particularly when bleb elevation is prominent in areas not protected by the eyelid. Prompt recognition and targeted conservative therapy may allow for complete recovery while preserving device function and visual outcomes. Surgeons should monitor the ocular surface for this complication and adjust postoperative management accordingly.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.